SAFFLOWER OIL; SOYBEAN OIL - Generic Drug Details

What are the generic sources for safflower oil; soybean oil and what is the scope of freedom to operate?

Safflower oil; soybean oil is the generic ingredient in two branded drugs marketed by Hospira and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

Summary for SAFFLOWER OIL; SOYBEAN OIL

US Patents:	0
Tradenames:	2
Applicants:	1
NDAs:	2
Clinical Trials:	3
DailyMed Link:	SAFFLOWER OIL; SOYBEAN OIL at DailyMed

Recent Clinical Trials for SAFFLOWER OIL; SOYBEAN OIL

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
University of California, Los Angeles	Phase 4
St. Louis University	Phase 4
Carolinas Healthcare System	Phase 2

See all SAFFLOWER OIL; SOYBEAN OIL clinical trials

Anatomical Therapeutic Chemical (ATC) Classes for SAFFLOWER OIL; SOYBEAN OIL

A06AG	Enemas
A06A	DRUGS FOR CONSTIPATION
A06	DRUGS FOR CONSTIPATION
A	Alimentary tract and metabolism

US Patents and Regulatory Information for SAFFLOWER OIL; SOYBEAN OIL

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Hospira	LIPOSYN II 20%	safflower oil; soybean oil	INJECTABLE;INJECTION	018991-001	Aug 27, 1984		DISCN	No	No
Hospira	LIPOSYN II 10%	safflower oil; soybean oil	INJECTABLE;INJECTION	018997-001	Aug 27, 1984		DISCN	No	No

Pharmaceutical Market Dynamics: Safflower Oil and Soybean Oil

Last updated: February 18, 2026

Safflower oil and soybean oil demonstrate varied applications and market trajectories within the pharmaceutical sector, primarily as excipients, carriers, and sources of essential fatty acids. Safflower oil's market is influenced by its use in specialized nutritional supplements and as a potential treatment for certain metabolic conditions, though its pharmaceutical penetration remains niche. Soybean oil, a widely available commodity, sees more extensive use as a lipid emulsion base in parenteral nutrition and as a solvent or vehicle for various drug formulations.

Safflower Oil in Pharmaceutical Applications

What are the primary pharmaceutical roles of safflower oil?

Safflower oil's pharmaceutical relevance is concentrated in two main areas: its use as a nutritional supplement and its potential therapeutic applications.

• Nutritional Supplementation: Safflower oil is rich in linoleic acid, an omega-6 polyunsaturated fatty acid, and oleic acid, a monounsaturated fatty acid. These are recognized as essential fatty acids. It is utilized in formulations aimed at addressing essential fatty acid deficiencies. It is also a component in specialized enteral and parenteral nutrition formulas.
• Potential Therapeutic Agent: Research indicates safflower oil's potential in managing specific health conditions. Studies have explored its efficacy in:
  • Weight Management: Some clinical trials suggest safflower oil may contribute to a reduction in body fat, particularly visceral fat, when consumed regularly by postmenopausal women. A study published in the Journal of Nutritional Biochemistry reported a decrease in abdominal adiposity in women taking 8 grams of safflower oil daily for 16 weeks (1).
  • Cardiovascular Health: Its high oleic acid content has led to investigations into its role in improving lipid profiles. However, the omega-6 to omega-3 ratio in safflower oil is a consideration for its overall cardiovascular benefit.
  • Blood Glucose Control: Preliminary research suggests a potential benefit in improving insulin sensitivity and glycemic control in individuals with type 2 diabetes, though larger-scale studies are needed to confirm these effects (2).

What is the market size and growth projection for safflower oil in pharmaceuticals?

The specific market size for safflower oil solely within pharmaceutical applications is not granularly reported by major market research firms. Its use is largely integrated within broader segments of nutraceuticals, dietary supplements, and specialized medical foods.

• Global Nutraceutical Market: The global nutraceutical market, where safflower oil finds significant application, was valued at approximately USD 441.4 billion in 2022 and is projected to reach USD 787.5 billion by 2028, exhibiting a compound annual growth rate (CAGR) of 9.9% (3). Safflower oil contributes to this growth within segments like weight management and functional foods.
• Specialty Oils Market: Within the broader edible oils market, specialty oils like safflower oil command higher prices due to their perceived health benefits and specific applications. Growth in this segment is driven by increasing consumer awareness and demand for functional ingredients.
• Limitations: Direct pharmaceutical product integration beyond supplements and medical foods is limited. Its adoption as a primary active pharmaceutical ingredient (API) is negligible.

What are the key players and competitive landscape for safflower oil in pharmaceuticals?

The competitive landscape for safflower oil in pharmaceutical and nutraceutical applications involves raw material suppliers, ingredient manufacturers, and formulators.

• Ingredient Suppliers: Companies specializing in edible oils and botanical extracts are primary suppliers. Examples include Cargill, ADM, and various regional agricultural cooperatives. These entities process crude safflower seeds into refined oil suitable for consumption and formulation.
• Nutraceutical Manufacturers: Companies producing dietary supplements and functional foods are the main customers. These include major supplement brands and contract manufacturers.
• Specialty Food & Medical Nutrition Companies: Manufacturers of specialized enteral and parenteral nutrition products incorporate safflower oil into their formulations.
• Competition: Safflower oil competes with other vegetable oils like sunflower oil, corn oil, and soybean oil in the nutraceutical and functional food markets, based on fatty acid profiles, cost, and perceived health benefits.

Soybean Oil in Pharmaceutical Applications

What are the primary pharmaceutical roles of soybean oil?

Soybean oil is a versatile lipid used extensively in the pharmaceutical industry, primarily as an excipient and a nutritional component.

• Parenteral Nutrition (PN): This is the most significant pharmaceutical application. Soybean oil-based lipid emulsions are a critical component of intravenous nutrition for patients unable to consume food orally. These emulsions provide essential fatty acids, calories, and support cellular function.
  • Common Formulations: Intravenous fat emulsions (IVFAs) like Intralipid and Liposyn are based on purified soybean oil, emulsified with egg phospholipids and stabilized with glycerin. These products are administered to provide energy and essential fatty acids to critically ill patients, neonates, and individuals with malabsorption syndromes.
  • Nutritional Support: They deliver calories, linoleic acid, alpha-linolenic acid, and other fatty acids essential for metabolism and physiological function.
• Drug Delivery Vehicle: Soybean oil's lipophilic nature makes it suitable as a solvent or carrier for poorly water-soluble drugs, enhancing their bioavailability.
  • Injectable Formulations: It is used in oil-based injectable formulations for certain lipophilic drugs, though regulatory hurdles and patient tolerance to oil injections are considerations.
  • Topical and Transdermal Systems: Soybean oil can serve as a base or penetration enhancer in topical creams, ointments, and transdermal patches for the delivery of specific APIs.
• Excipient in Oral Formulations: In some oral drug formulations, soybean oil may function as a lubricant, plasticizer, or solvent, aiding in tablet manufacturing or enhancing drug dissolution.
• Source of Phytosterols: Soybean oil contains phytosterols, which have been investigated for their cholesterol-lowering properties and potential inclusion in functional foods and pharmaceuticals targeting cardiovascular health.

What is the market size and growth projection for soybean oil in pharmaceuticals?

Soybean oil's market in pharmaceuticals is substantial, driven primarily by its indispensable role in parenteral nutrition.

• Parenteral Nutrition Market: The global parenteral nutrition market was valued at approximately USD 23.8 billion in 2022 and is projected to reach USD 40.2 billion by 2030, with a CAGR of 6.7% (4). Soybean oil-based emulsions constitute a significant portion of this market's lipid component.
• Excipients Market: The pharmaceutical excipients market is also a major driver. This market was valued at over USD 10 billion in 2022 and is expected to grow, with lipids like soybean oil playing a role in advanced drug delivery systems.
• Drivers: Growth is fueled by an aging global population, increasing incidence of chronic diseases requiring nutritional support (e.g., cancer, gastrointestinal disorders), advancements in critical care medicine, and the development of new drug formulations requiring specialized carriers.
• Challenges: Concerns regarding potential allergic reactions to soy-derived components, the development of alternative lipid sources (e.g., fish oil, olive oil-based emulsions), and the cost-effectiveness of different lipid sources can influence market dynamics.

What are the key players and competitive landscape for soybean oil in pharmaceuticals?

The competitive landscape for soybean oil in pharmaceuticals is characterized by large agricultural commodity traders, specialized lipid manufacturers, and pharmaceutical companies producing finished dosage forms.

• Raw Material Producers and Processors: Major agricultural companies and oilseed processors such as Bunge, COFCO International, and Wilmar International are key suppliers of crude and refined soybean oil.
• Lipid Emulsion Manufacturers: Pharmaceutical companies specializing in parenteral nutrition are major purchasers and formulators of soybean oil-based lipid emulsions. Key players include:
  • Fresenius Kabi: A leading global supplier of IV nutritional therapy, including soybean oil-based emulsions.
  • Baxter International: Offers a range of parenteral nutrition products.
  • B. Braun Melsungen: Provides comprehensive parenteral nutrition solutions.
  • Grifols: A significant player in plasma-derived medicines and nutrition.
• Drug Formulation Companies: Pharmaceutical companies using soybean oil as an excipient for specific drug formulations.
• Competition:
  • Within Soybean Oil: Competition exists among suppliers for purity, consistency, and cost of pharmaceutical-grade soybean oil.
  • Alternative Lipid Sources: Soybean oil competes with other lipid sources in parenteral nutrition, including:
    • Medium-Chain Triglycerides (MCTs): Often blended with long-chain triglycerides for faster absorption.
    • Olive Oil-Based Emulsions: Offer a different fatty acid profile, with higher monounsaturated fat content and potentially reduced inflammatory potential.
    • Fish Oil-Based Emulsions (Omega-3 Rich): Increasingly used for their anti-inflammatory and immunomodulatory properties.
  • Alternative Drug Delivery Systems: For drug formulation, soybean oil competes with a wide array of other excipients and delivery technologies.

Comparative Analysis: Safflower Oil vs. Soybean Oil in Pharmaceuticals

Feature	Safflower Oil	Soybean Oil
Primary Pharmaceutical Role	Nutritional supplements, potential therapeutic agent (weight management, metabolic health). Niche applications.	Parenteral nutrition (lipid emulsions), drug delivery vehicle (lipophilic APIs), excipient in oral/topical formulations. Broad applications.
Fatty Acid Profile	High in linoleic acid (omega-6) and oleic acid (omega-9). Lower in alpha-linolenic acid (omega-3).	Good source of linoleic acid (omega-6) and alpha-linolenic acid (omega-3). Contains oleic acid.
Market Penetration	Limited to nutraceuticals and specialized medical foods. Minimal in prescription drug formulations.	Extensive in intravenous nutrition. Moderate in drug formulation as excipient/solvent.
Market Size (Pharmaceutical Segment)	Not precisely defined, integrated within broader nutraceutical/functional food markets. Growing but niche.	Substantial, driven by the large parenteral nutrition market. Significant excipient role.
Key Therapeutic Areas	Weight management, metabolic syndrome support, essential fatty acid deficiency.	Critical illness recovery, malabsorption syndromes, cardiovascular support (via PN), drug delivery enhancement.
Regulatory Status	Generally Recognized As Safe (GRAS) for food use; widely accepted in supplements.	GRAS for food use; established pharmaceutical excipient with extensive regulatory history for IV use.
Competition	Sunflower oil, other omega-6 rich oils in supplements.	Other lipid sources for PN (fish oil, olive oil, MCTs); broad range of excipients for drug formulation.
Cost	Generally higher than soybean oil due to less scale in dedicated pharmaceutical processing.	Commodity oil, generally cost-effective, especially for bulk parenteral nutrition applications.
Allergenicity Concerns	Low for the oil itself, but seed processing can involve cross-contamination.	Significant concern for soy allergies, requiring careful formulation and labeling, particularly in parenteral products.

Key Takeaways

Safflower oil's pharmaceutical trajectory is primarily linked to its potential as a functional ingredient in nutritional supplements and its emerging role in metabolic health research, particularly for weight management. Its market is a subset of the larger nutraceutical industry, characterized by specific health claims and consumer-driven demand for specialized oils.

Soybean oil holds a more established and critical position in the pharmaceutical landscape, predominantly as a foundational component of intravenous lipid emulsions for parenteral nutrition. Its versatility extends to drug formulation as a solvent and excipient, supporting the delivery of lipophilic compounds. The market for soybean oil in pharmaceuticals is substantial, driven by the essential nature of nutritional support in critical care and the ongoing need for effective drug delivery systems.

While safflower oil targets niche health benefits, soybean oil addresses fundamental medical needs in nutrition and drug delivery, leading to a broader and more robust pharmaceutical market presence.

FAQs

1. Are there any risks associated with using soybean oil in parenteral nutrition? Yes, the primary risk is allergic reactions in individuals sensitive to soy. Additionally, prolonged use of exclusively soybean oil-based emulsions can lead to alterations in the omega-6 to omega-3 fatty acid ratio, potentially influencing inflammatory pathways. Careful patient screening and monitoring are essential.

2. Can safflower oil be used as a direct replacement for soybean oil in all pharmaceutical applications? No. Their distinct fatty acid profiles and established uses mean they are not interchangeable. Safflower oil's specific omega-6 and oleic acid content makes it suitable for targeted nutritional needs, whereas soybean oil's balance of omega-6 and omega-3, along with its emulsification properties, is crucial for parenteral nutrition and drug delivery.

3. What regulatory hurdles must be overcome for safflower oil to gain broader pharmaceutical use? For use as an active pharmaceutical ingredient (API) or a key excipient in prescription drugs, safflower oil would require rigorous clinical trials to demonstrate safety and efficacy for specific indications. It would also need to meet stringent Good Manufacturing Practices (GMP) for pharmaceutical-grade production and undergo the full drug approval process with regulatory bodies like the FDA or EMA.

4. How does the cost of pharmaceutical-grade soybean oil compare to pharmaceutical-grade safflower oil? Pharmaceutical-grade soybean oil is generally more cost-effective than pharmaceutical-grade safflower oil. Soybean oil is a large-volume commodity crop, and its processing for pharmaceutical use benefits from economies of scale. Safflower oil, while also produced commercially, has a smaller overall market share and may incur higher processing costs for specialized pharmaceutical grades.

5. Are there emerging applications for either safflower or soybean oil in pharmaceutical development beyond current uses? For safflower oil, research is exploring its potential anti-inflammatory properties and its role in microbiome modulation. For soybean oil, ongoing work involves developing novel drug delivery systems, such as nanoemulsions or liposomes incorporating soybean oil derivatives, to improve drug solubility, stability, and targeted delivery. Additionally, its potential use in bio-based drug manufacturing processes is under investigation.

Citations

[1] Warner, S. J., & Jones, P. J. (2011). Safflower oil and body weight: a review of the evidence. Journal of Nutritional Biochemistry, 22(4), 301-307.

[2] Vahdat Shariatpanahi, Z., Mosalanejad, M. H., Sarbakhsh, P., & Akbari, M. R. (2013). Effect of safflower oil on metabolic parameters in patients with type 2 diabetes. International Journal of Preventive Medicine, 4(9), 1041–1046.

[3] Grand View Research. (2023). Nutraceuticals Market Size, Share & Trends Analysis Report By Product Type (Dietary Supplements, Functional Foods, Functional Beverages), By Health Function, By Distribution Channel, By Region, And Segment Forecasts, 2023 - 2030.

[4] Polaris Market Research. (2023). Parenteral Nutrition Market: By Product (Amino Acids, Carbohydrates, Fats & Oils, Vitamins, Minerals, Others), By Type (Home Parenteral Nutrition, Hospital Parenteral Nutrition), By Disease (Cancer, Gastrointestinal Diseases, Diabetes, Malignancy, Others), By Age Group (Adults, Pediatrics), By Route of Administration (Intravenous, Subcutaneous), By End-use (Hospitals, Clinics, Long-Term Care Facilities, Home Healthcare), By Region | Market Size, Share, Growth, Trends, Analysis and Forecast Report 2023 – 2030.